SEC Filings | NeuroBo Pharmaceuticals, Inc.

Filing date	Form	Description	Filing Group	View
Dec 7, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	0001558370-23-019584.rtf 0001558370-23-019584.xls NeuroBo_Pharmaceuticals_Inc._20231207_8-K_EDGAR_Bannerless.pdf View HTML
Dec 4, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001527710-23-000003.rtf 0001527710-23-000003.xls 0001527710-23-000003.pdf View HTML
Nov 13, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	0001558370-23-018835.rtf 0001558370-23-018835.xls 0001558370-23-018835.pdf View HTML
Nov 13, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	0001558370-23-018842.rtf 0001558370-23-018842.xls 0001558370-23-018842.pdf View HTML
Nov 6, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	0001558370-23-017666.rtf 0001558370-23-017666.xls 0001558370-23-017666.pdf View HTML
Nov 2, 2023	3	Initial filing by director officer or owner of more than ten percent	3,4,5	0001527710-23-000002.rtf 0001527710-23-000002.xls 0001527710-23-000002.pdf View HTML
Oct 30, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	0001558370-23-016982.rtf 0001558370-23-016982.xls 0001558370-23-016982.pdf View HTML
Oct 30, 2023	3	Initial filing by director officer or owner of more than ten percent	3,4,5	0001492648-23-000003.rtf 0001492648-23-000003.xls 0001492648-23-000003.pdf View HTML
Sep 22, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	0001558370-23-015921v2.rtf 0001558370-23-015921.xls 0001558370-23-015921v2.pdf View HTML
Sep 19, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	0001558370-23-015884.rtf 0001558370-23-015884.xls 0001558370-23-015884.pdf View HTML

Data provided by Kaleidoscope.